Oruka Therapeutics CEO Lawrence Klein disposes of $2.09 million in common shares
ORKA•CEO Lawrence Klein exercised a warrant for 25,000 Oruka Therapeutics shares at $7.80 and sold 25,000 shares on Oct. 1, 2026, at weighted-average prices of $83.3979, $84.0256 and $84.78.
1. Share transactions
Klein exercised an employee warrant for 25,000 shares at $7.80 on Oct. 1, 2026, and sold 25,000 shares that day at weighted-average prices of $83.3979, $84.0256 and $84.78. His directly held common stock fell to 923,128 shares following the transactions.
